circLMTK2 functions as a tumour promoter in GC through the miR-150-5p/c-Myc axis and could thus be a prognostic predictor and therapeutic target for GC.
circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer.